Biotechs
Australia
Paul Perreault
20,000
$7.4B
Parkville
CSL is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since its start in 1916, CSL has been driven by its promise to save lives using the latest technologies. Today, CSL — including its two businesses, CSL Behring and Seqirus - provides life-saving products to more than 60 countries and employs 20,000 people. CSL’s unique combination of commercial strength, R&D focus andRead More operational excellence enable it to identify, develop and deliver innovations so patients can live life to the fullest.